These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8831211)

  • 1. [Enhancement of cytotoxic effect of anticancer agents of renal cell carcinoma].
    Okano M; Kawamoto S; Nezasa S; Tamaki M; Ehara H; Yamada S; Deguchi T; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1041-7. PubMed ID: 8831211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumvention of multidrug resistance by a quinoline derivative, MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil.
    Shrivastava P; Hanibuchi M; Yano S; Parajuli P; Tsuruo T; Sone S
    Cancer Chemother Pharmacol; 1998; 42(6):483-90. PubMed ID: 9788575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A has low potency as a calcineurin inhibitor in cells expressing high levels of P-glycoprotein.
    Fakata KL; Elmquist WF; Swanson SA; Vorce RL; Prince C; Stemmer PM
    Life Sci; 1998; 62(26):2441-8. PubMed ID: 9651111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
    Jetté L; Murphy GF; Béliveau R
    Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
    Wang L; Kitaichi K; Hui CS; Takagi K; Takagi K; Sakai M; Yokogawa K; Miyamoto KI; Hasegawa T
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):587-93. PubMed ID: 10901387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of P-glycoprotein expression by tumoral cells with NBDL-CsA, a fluorescent derivative of cyclosporin A.
    Didier A; Tiberghien F; Wenger R; Loor F
    Anticancer Drugs; 1996 May; 7(3):257-65. PubMed ID: 8791998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of expression levels of P-glycoprotein with resistance to adriamycin in a renal adenocarcinoma cell line.
    Kawamoto S; Deguchi T; Nezesa S; Yamada S; Okano M; Kawada Y
    Urol Res; 1997; 25(6):407-12. PubMed ID: 9443650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of established tumors expressing P-glycoprotein by combinations of adriamycin, cyclosporin derivatives, and MRK-16 antibodies.
    Watanabe T; Naito M; Kokubu N; Tsuruo T
    J Natl Cancer Inst; 1997 Apr; 89(7):512-8. PubMed ID: 9086008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma.
    Mickisch GH; Roehrich K; Koessig J; Forster S; Tschada RK; Alken PM
    J Urol; 1990 Sep; 144(3):755-9. PubMed ID: 1974934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416.
    Xu Y; Zhi F; Xu G; Tang X; Lu S; Wu J; Hu Y
    Biosci Rep; 2012 Dec; 32(6):559-66. PubMed ID: 22757751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
    Nygren P; Larsson R
    Int J Cancer; 1991 Jun; 48(4):598-604. PubMed ID: 2045203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of mdr-1-related gp-170 and its correlation with anthracycline resistance in renal cell carcinoma cell lines and multidrug-resistant sublines.
    Yu DS; Chang SY; Ma CP
    Br J Urol; 1998 Oct; 82(4):544-7. PubMed ID: 9806185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of CCN1 with αvβ3 integrin induces P-glycoprotein and confers vinblastine resistance in renal cell carcinoma cells.
    Long QZ; Zhou M; Liu XG; Du YF; Fan JH; Li X; He DL
    Anticancer Drugs; 2013 Sep; 24(8):810-7. PubMed ID: 23744557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verapamil and cyclosporin A sensitize human kidney tumor cells to vincristine in absence of membrane P-glycoprotein and without apparent changes in the cytoplasmic free Ca2+ concentration.
    Nygren P; Larsson R
    Biosci Rep; 1990 Apr; 10(2):231-7. PubMed ID: 1972632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
    Watanabe T; Tsuge H; Oh-Hara T; Naito M; Tsuruo T
    Acta Oncol; 1995; 34(2):235-41. PubMed ID: 7718262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A.
    Saito T; Zhang ZJ; Tokuriki M; Shibamori Y; Yamamoto T; Noda I; Ohtsubo T; Saito H
    Acta Otolaryngol; 2001 Oct; 121(7):787-93. PubMed ID: 11718240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of verapamil analogs and reversal of multidrug resistance.
    Toffoli G; Simone F; Corona G; Raschack M; Cappelletto B; Gigante M; Boiocchi M
    Biochem Pharmacol; 1995 Oct; 50(8):1245-55. PubMed ID: 7488241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on chemosensitivity test of urogenital tumors by ATP assay].
    Yamada S; Deguchi T; Nezasa S; Tamaki M; Ehara H; Okano M; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):2022-8. PubMed ID: 1474710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.